Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification.
De Bernardi B, Gerrard M, Boni L, Rubie H, Cañete A, Di Cataldo A, Castel V, Forjaz de Lacerda A, Ladenstein R, Ruud E, Brichard B, Couturier J, Ellershaw C, Munzer C, Bruzzi P, Michon J, Pearson AD. De Bernardi B, et al. Among authors: ellershaw c. J Clin Oncol. 2009 Mar 1;27(7):1034-40. doi: 10.1200/JCO.2008.17.5877. Epub 2009 Jan 26. J Clin Oncol. 2009. PMID: 19171711 Clinical Trial.
High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial.
Pearson AD, Pinkerton CR, Lewis IJ, Imeson J, Ellershaw C, Machin D; European Neuroblastoma Study Group; Children's Cancer and Leukaemia Group (CCLG formerly United Kingdom Children's Cancer Study Group). Pearson AD, et al. Among authors: ellershaw c. Lancet Oncol. 2008 Mar;9(3):247-56. doi: 10.1016/S1470-2045(08)70069-X. Lancet Oncol. 2008. PMID: 18308250 Clinical Trial.
Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors.
Lastowska M, Cullinane C, Variend S, Cotterill S, Bown N, O'Neill S, Mazzocco K, Roberts P, Nicholson J, Ellershaw C, Pearson AD, Jackson MS; United Kingdom Children Cancer Study Group and the United Kingdom Cancer Cytogenetics Group. Lastowska M, et al. Among authors: ellershaw c. J Clin Oncol. 2001 Jun 15;19(12):3080-90. doi: 10.1200/JCO.2001.19.12.3080. J Clin Oncol. 2001. PMID: 11408505
OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
Tweddle DA, Pinkerton CR, Lewis IJ, Ellershaw C, Cole M, Pearson AD. Tweddle DA, et al. Among authors: ellershaw c. Med Pediatr Oncol. 2001 Jan;36(1):239-42. doi: 10.1002/1096-911X(20010101)36:1<239::AID-MPO1058>3.0.CO;2-G. Med Pediatr Oncol. 2001. PMID: 11464894 Clinical Trial.
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients.
Veal GJ, Cole M, Errington J, Pearson AD, Gerrard M, Whyman G, Ellershaw C, Boddy AV. Veal GJ, et al. Among authors: ellershaw c. Cancer Chemother Pharmacol. 2010 May;65(6):1057-66. doi: 10.1007/s00280-009-1111-9. Epub 2009 Aug 23. Cancer Chemother Pharmacol. 2010. PMID: 19701749 Clinical Trial.
Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group.
George RE, Variend S, Cullinane C, Cotterill SJ, McGuckin AG, Ellershaw C, Lunec J, Pearson AD; United Kingdom Children Cancer Study Group. George RE, et al. Among authors: ellershaw c. Med Pediatr Oncol. 2001 Jan;36(1):169-76. doi: 10.1002/1096-911X(20010101)36:1<169::AID-MPO1041>3.0.CO;2-U. Med Pediatr Oncol. 2001. PMID: 11464876 Review.
17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
Bown N, Lastowska M, Cotterill S, O'Neill S, Ellershaw C, Roberts P, Lewis I, Pearson AD; U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. Bown N, et al. Among authors: ellershaw c. Med Pediatr Oncol. 2001 Jan;36(1):14-9. doi: 10.1002/1096-911X(20010101)36:1<14::AID-MPO1005>3.0.CO;2-G. Med Pediatr Oncol. 2001. PMID: 11464868
Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors.
Carlin S, Mairs RJ, McCluskey AG, Tweddle DA, Sprigg A, Estlin C, Board J, George RE, Ellershaw C, Pearson AD, Lunec J, Montaldo PG, Ponzoni M, van Eck-Smit BL, Hoefnagel CA, van den Brug MD, Tytgat GA, Caron HN. Carlin S, et al. Among authors: ellershaw c. Clin Cancer Res. 2003 Aug 15;9(9):3338-44. Clin Cancer Res. 2003. PMID: 12960120
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Stevens MC, Rey A, Bouvet N, Ellershaw C, Flamant F, Habrand JL, Marsden HB, Martelli H, Sanchez de Toledo J, Spicer RD, Spooner D, Terrier-Lacombe MJ, van Unnik A, Oberlin O. Stevens MC, et al. Among authors: ellershaw c. J Clin Oncol. 2005 Apr 20;23(12):2618-28. doi: 10.1200/JCO.2005.08.130. Epub 2005 Feb 22. J Clin Oncol. 2005. PMID: 15728225 Clinical Trial.
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.
Oberlin O, Rey A, Sanchez de Toledo J, Martelli H, Jenney ME, Scopinaro M, Bergeron C, Merks JH, Bouvet N, Ellershaw C, Kelsey A, Spooner D, Stevens MC. Oberlin O, et al. Among authors: ellershaw c. J Clin Oncol. 2012 Jul 10;30(20):2457-65. doi: 10.1200/JCO.2011.40.3287. Epub 2012 Jun 4. J Clin Oncol. 2012. PMID: 22665534 Clinical Trial.
15 results